(1)
Srilar, P.; Ramart, P.; Nualyong, C.; Soontrapa, S.; Sujijantararat, P.; Leewansangtong, S.; Srinualnad, S.; Taweemonkongsap, T.; Chaiyaprasithi, B.; Amornvesukit, T.; Phinthusophon, K. Comparison of 1 Year Recurrent Rate in High-Risk of Recurrent Non-Muscle Invasive Bladder Cancer Who Had Received Induction Course of Intravesical BCG After TUR-BT Between Combination With Immediate Intravesical Mitomycin C and Induction Course of Intrave. Insight Urol 2012, 33, 34-42.